Skeletal muscle atrophy and short-term mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis: an observational cohort study

Y Ito, K Anan, N Awano, Y Kataoka, T Johkoh… - Respiratory …, 2023 - Elsevier
Background Skeletal muscle atrophy, a common complication of idiopathic pulmonary
fibrosis (IPF), and its presence upon diagnosis can indicate a poor prognosis. Patients with …

Quantitative computed tomography measures of skeletal muscle mass in patients with idiopathic pulmonary fibrosis according to a multidisciplinary discussion …

N Awano, M Inomata, N Kuse, M Tone… - Respiratory …, 2020 - Elsevier
Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease often accompanied
by skeletal muscle wasting. We investigated whether skeletal muscle mass and muscle …

[HTML][HTML] Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients

SW Moon, JS Choi, SH Lee, KS Jung, JY Jung… - Respiratory …, 2019 - Springer
Background Sarcopenia can contribute to negative outcomes in patients with various lung
diseases. However, whether sarcopenia affects prognosis in patients with idiopathic …

Reduced CT-derived erector spinae muscle area: a poor prognostic factor for short-and long-term outcomes in idiopathic pulmonary fibrosis patients

A Çinkooğlu, S Bayraktaroğlu, F Ufuk, ÖS Unat, T Köse… - Clinical Radiology, 2023 - Elsevier
AIM To assess the relationship between idiopathic pulmonary fibrosis (IPF) prognosis,
baseline skeletal muscle mass, and attenuation on computed tomography (CT) and clinical …

[HTML][HTML] Early decrease in erector spinae muscle area and future risk of mortality in idiopathic pulmonary fibrosis

A Nakano, H Ohkubo, H Taniguchi, Y Kondoh… - Scientific reports, 2020 - nature.com
Computed tomography (CT) assessment of the cross-sectional area of the erector spinae
muscles (ESMCSA) can be used to evaluate sarcopenia and cachexia in patients with lung …

Appendicular skeletal muscle mass correlates with patient-reported outcomes and physical performance in patients with idiopathic pulmonary fibrosis

K Ebihara, Y Iwanami, K Yamasaki… - The Tohoku Journal of …, 2021 - jstage.jst.go.jp
Idiopathic pulmonary fibrosis (IPF), an incurable lung disease of unknown cause, often
presents with losses of skeletal muscle mass. IPF requires comprehensive care, but it has …

Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy

Y Suzuki, Y Aono, M Kono, H Hasegawa… - …, 2021 - Wiley Online Library
Background and objective Recent research has highlighted the fundamental role of
sarcopenia, characterized by loss of skeletal muscle mass and strength, with a risk of poor …

Acute exacerbation and decline in forced vital capacity are associated with increased mortality in idiopathic pulmonary fibrosis

MO Paterniti, Y Bi, D Rekić, Y Wang… - Annals of the …, 2017 - atsjournals.org
Rationale: Exploration of FVC as it relates to mortality in idiopathic pulmonary fibrosis (IPF),
a chronic, progressive, and ultimately fatal parenchymal lung disease, is important both …

Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta‐analysis

M Qiu, Y Chen, Q Ye - The clinical respiratory journal, 2018 - Wiley Online Library
Background Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic disease
limited to the lungs. The course of disease varies widely, with some patients experiencing …

The effect of emphysema in patients with idiopathic pulmonary fibrosis; evaluation using quantitative ct analysis

H Nakagawa, Y Higami, K Fukunaga, Y Uchida… - 2016 - Eur Respiratory Soc
BACKGROUND: Many patients with idiopathic pulmonary fibrosis (IPF) have smoking history
and emphysematous lesions. However, there are no reports using quantitative computed …